Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) EBITDA (2016 - 2025)

Historic EBITDA for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to -$1.4 million.

  • Iridex's EBITDA rose 2454.55% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year increase of 7189.85%. This contributed to the annual value of -$8.3 million for FY2024, which is 1703.81% up from last year.
  • Per Iridex's latest filing, its EBITDA stood at -$1.4 million for Q3 2025, which was up 2454.55% from -$940000.0 recorded in Q2 2025.
  • Over the past 5 years, Iridex's EBITDA peaked at -$205000.0 during Q1 2025, and registered a low of -$3.3 million during Q1 2024.
  • Over the past 5 years, Iridex's median EBITDA value was -$1.8 million (recorded in 2021), while the average stood at -$1.8 million.
  • Per our database at Business Quant, Iridex's EBITDA crashed by 11851.06% in 2023 and then soared by 9377.47% in 2025.
  • Over the past 5 years, Iridex's EBITDA (Quarter) stood at -$2.2 million in 2021, then surged by 34.63% to -$1.4 million in 2022, then tumbled by 118.51% to -$3.1 million in 2023, then surged by 83.71% to -$502000.0 in 2024, then tumbled by 181.08% to -$1.4 million in 2025.
  • Its EBITDA stands at -$1.4 million for Q3 2025, versus -$940000.0 for Q2 2025 and -$205000.0 for Q1 2025.